Physician profile
Michael A Elrod
NPI 1629001359
$11,670.51
in general payments reported to CMS, 2019-2025
16 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $440 · 2020: $4,189 · 2021: $3,759 · 2022: $676 · 2023: $739 · 2024: $1,722 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,420 · Education: $1,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,420.05 |
| Education | $1,185.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,369.63 | 2020-2024 | Da Vinci Surgical System |
| Davol INC. | $689.71 | 2019-2024 | Phasix Mesh |
| Ethicon US, LLC | $545.96 | 2020-2025 | Echelon; Endopath, Ethicon, Evarrest |
| Avanos Medical | $419.22 | 2019-2024 | On-Q* Pump and Accessories |
| Integra Lifesciences Corporation | $403.70 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Sanara Medtech INC. | $226.50 | 2022-2025 | Celleraterx, Celleraterx |
| Smith+Nephew, INC. | $207.06 | 2023-2024 | Pico 7, Renasys Touch, Renasys Go V2 Home |
| Abbvie INC. | $148.19 | 2021-2022 | |
| Kci USA, INC. | $140.07 | 2019-2022 | |
| Solventum Corporation | $136.76 | 2024-2025 | Prevena, V.A.C.Ulta, V.A.C. Veraflo |
| Becton, Dickinson and Company | $130.99 | 2019 | |
| Covidien LP | $109.77 | 2019 | |
| Baxter Healthcare | $88.37 | 2019-2025 | Perclot |
| Allergan, INC. | $23.40 | 2020 | |
| Wound Management Technologies, INC | $17.59 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leica Microsystems INC. | $13.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Elrod listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.